CIK 1911010
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2024-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 91.02% | 13 |
| Unclassified | 8.98% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Health Care | 53.94% |
| 2 | TYRA | Tyra Biosciences, Inc. | Health Care | 9.15% |
| 3 | ORIC | Oric Pharmaceuticals, Inc. | Health Care | 6.92% |
| 4 | CARGO THERAPEUTICS INC COM | Unclassified | 6.18% | |
| 5 | ARVN | ARVINAS, INC. | Health Care | 4.38% |
| 6 | MERSANA THERAPEUTICS INC COM | Unclassified | 2.80% | |
| 7 | TNGX | Tango Therapeutics, Inc. | Health Care | 2.77% |
| 8 | ZYME | Zymeworks Inc. | Health Care | 2.65% |
| 9 | RLAY | Relay Therapeutics, Inc. | Health Care | 2.57% |
| 10 | CGEM | Cullinan Therapeutics, Inc. | Health Care | 2.25% |
13/15 names classified · sector 91.0% of weight · industry 91.0% · mkt cap 91.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 91.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/14 names) · unclassified 100.0%: RVMD, TYRA, , ORIC, ARVN, TNGX, ZYME, RLAY, CGEM, ALMS +4 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 7,601,087 | $332M | 53.9% | ADD 21% |
| 2 | TYRATYRA BIOSCIENCES INC | 4,055,861 | $56M | 9.1% | HOLD |
| 3 | ORICORIC PHARMACEUTICALS INC | 5,285,714 | $43M | 6.9% | HOLD |
| 4 | CARGO THERAPEUTICS INC COM | 2,642,502 | $38M | 6.2% | HOLD |
| 5 | ARVNARVINAS INC | 1,408,394 | $27M | 4.4% | HOLD |
| 6 | MERSANA THERAPEUTICS INC COM | 12,067,246 | $17M | 2.8% | HOLD |
| 7 | TNGXTANGO THERAPEUTICS INC | 5,533,980 | $17M | 2.8% | HOLD |
| 8 | ZYMEZYMEWORKS INC | 1,113,946 | $16M | 2.6% | HOLD |
| 9 | RLAYRELAY THERAPEUTICS INC | 3,846,409 | $16M | 2.6% | HOLD |
| 10 | CGEMCULLINAN THERAPEUTICS INC | 1,141,145 | $14M | 2.3% | HOLD |
| 11 | ALMSALUMIS INC | 1,476,998 | $12M | 1.9% | HOLD |
| 12 | SPRYARS PHARMACEUTICALS INC | 936,729 | $10M | 1.6% | TRIM −16% |
| 13 | CNTXCONTEXT THERAPEUTICS INC | 7,419,355 | $8M | 1.3% | HOLD |
| 14 | SLNSILENCE THERAPEUTICS PLC | 952,400 | $7M | 1.1% | HOLD |
| 15 | BOLDBOUNDLESS BIO INC | 1,228,069 | $4M | 0.6% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
